| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $712.5M | -6.9% |
| Cost of Revenue | $359.8M | -14.7% |
| Gross Profit | $352.8M | +2.8% |
| R&D Expense | $60.4M | -7.1% |
| SG&A Expense | $73.0M | -14.2% |
| Operating Income | $76.1M | +8.8% |
| Interest Expense | $326K | +0.9% |
| Pre-tax Income | $88.9M | +11.4% |
| Income Tax | $26.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.1M | +63.3% |
| Short-term Investments | $104.8M | +1.8% |
| Accounts Receivable | $102.0M | -8.3% |
| Inventory | $134.3M | -51.6% |
| Current Assets | $580.2M | -6.4% |
| Total Assets | $693.0M | -7.6% |
| Current Liabilities | $203.4M | +3.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $265.0M | -8.0% |
| Investing Cash Flow | -$18.3M | +62.4% |
| Financing Cash Flow | -$156.4M | +51.4% |
| -0.4% |
| Net Income | $62.8M | +17.1% |
| EPS (Basic) | $0.29 | +16.0% |
| EPS (Diluted) | $0.29 | +20.8% |
| Total Liabilities |
| $226.3M |
| +5.1% |
| Stockholders' Equity | $466.8M | -12.7% |